FIBB_HUMAN - dbPTM
FIBB_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID FIBB_HUMAN
UniProt AC P02675
Protein Name Fibrinogen beta chain
Gene Name FGB
Organism Homo sapiens (Human).
Sequence Length 491
Subcellular Localization Secreted .
Protein Description Cleaved by the protease thrombin to yield monomers which, together with fibrinogen alpha (FGA) and fibrinogen gamma (FGG), polymerize to form an insoluble fibrin matrix. Fibrin has a major function in hemostasis as one of the primary components of blood clots. In addition, functions during the early stages of wound repair to stabilize the lesion and guide cell migration during re-epithelialization. Was originally thought to be essential for platelet aggregation, based on in vitro studies using anticoagulated blood. However subsequent studies have shown that it is not absolutely required for thrombus formation in vivo. Enhances expression of SELP in activated platelets. Maternal fibrinogen is essential for successful pregnancy. Fibrin deposition is also associated with infection, where it protects against IFNG-mediated hemorrhage. May also facilitate the antibacterial immune response via both innate and T-cell mediated pathways..
Protein Sequence MKRMVSWSFHKLKTMKHLLLLLLCVFLVKSQGVNDNEEGFFSARGHRPLDKKREEAPSLRPAPPPISGGGYRARPAKAAATQKKVERKAPDAGGCLHADPDLGVLCPTGCQLQEALLQQERPIRNSVDELNNNVEAVSQTSSSSFQYMYLLKDLWQKRQKQVKDNENVVNEYSSELEKHQLYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFFPQQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
30PhosphorylationLCVFLVKSQGVNDNE
HHHHHHHHCCCCCCC
25.3724505115
31Pyrrolidone_carboxylic_acidCVFLVKSQGVNDNEE
HHHHHHHCCCCCCCC
54.88420779
31Pyrrolidone_carboxylic_acidCVFLVKSQGVNDNEE
HHHHHHHCCCCCCCC
54.88420779
31Pyrrolidone_carboxylic_acidCVFLVKSQGVNDNEE
HHHHHHHCCCCCCCC
54.88-
58PhosphorylationKKREEAPSLRPAPPP
CCCCCCCCCCCCCCC
44.0228060719
58O-linked_GlycosylationKKREEAPSLRPAPPP
CCCCCCCCCCCCCCC
44.02OGP
67PhosphorylationRPAPPPISGGGYRAR
CCCCCCCCCCCCCCC
36.8428857561
71PhosphorylationPPISGGGYRARPAKA
CCCCCCCCCCCCCHH
12.3628857561
71NitrationPPISGGGYRARPAKA
CCCCCCCCCCCCCHH
12.36-
108O-linked_GlycosylationDLGVLCPTGCQLQEA
CCCCCCCCCHHHHHH
49.98OGP
138PhosphorylationNNNVEAVSQTSSSSF
HHCHHHHHCCCCHHH
34.49-
147NitrationTSSSSFQYMYLLKDL
CCCHHHHHHHHHHHH
5.92-
149NitrationSSSFQYMYLLKDLWQ
CHHHHHHHHHHHHHH
12.16-
172NitrationNENVVNEYSSELEKH
CHHHHHHHHHHHHHC
16.58-
172PhosphorylationNENVVNEYSSELEKH
CHHHHHHHHHHHHHC
16.5828060719
173PhosphorylationENVVNEYSSELEKHQ
HHHHHHHHHHHHHCC
15.9126657352
174PhosphorylationNVVNEYSSELEKHQL
HHHHHHHHHHHHCCE
45.3524505115
182NitrationELEKHQLYIDETVNS
HHHHCCEECCHHHHC
10.35-
182PhosphorylationELEKHQLYIDETVNS
HHHHCCEECCHHHHC
10.3522817900
200PhosphorylationTNLRVLRSILENLRS
HHHHHHHHHHHHHHH
27.6230087585
208AcetylationILENLRSKIQKLESD
HHHHHHHHHHHHHHC
42.6024471073
227S-nitrosylationMEYCRTPCTVSCNIP
HHHCCCCCEEEECCC
6.0825040305
228PhosphorylationEYCRTPCTVSCNIPV
HHCCCCCEEEECCCE
19.3623911959
230PhosphorylationCRTPCTVSCNIPVVS
CCCCCEEEECCCEEC
5.3628857561
231S-nitrosylationRTPCTVSCNIPVVSG
CCCCEEEECCCEECC
4.6825040305
237PhosphorylationSCNIPVVSGKECEEI
EECCCEECCHHHHHH
44.3623911959
255PhosphorylationGGETSEMYLIQPDSS
CCCCCEEEEECCCCC
9.15-
261PhosphorylationMYLIQPDSSVKPYRV
EEEECCCCCCCCEEE
43.65-
262PhosphorylationYLIQPDSSVKPYRVY
EEECCCCCCCCEEEE
41.35-
264AcetylationIQPDSSVKPYRVYCD
ECCCCCCCCEEEEEE
37.9822507986
266PhosphorylationPDSSVKPYRVYCDMN
CCCCCCCEEEEEECC
13.64-
269PhosphorylationSVKPYRVYCDMNTEN
CCCCEEEEEECCCCC
3.61-
280PhosphorylationNTENGGWTVIQNRQD
CCCCCCEEEEECCCC
15.82-
289PhosphorylationIQNRQDGSVDFGRKW
EECCCCCCCCCCCCC
27.1428857561
295AcetylationGSVDFGRKWDPYKQG
CCCCCCCCCCCCCCC
57.2227178108
295GlycationGSVDFGRKWDPYKQG
CCCCCCCCCCCCCCC
57.22-
299PhosphorylationFGRKWDPYKQGFGNV
CCCCCCCCCCCCCCE
17.3025690035
300AcetylationGRKWDPYKQGFGNVA
CCCCCCCCCCCCCEE
49.7030585635
313AcetylationVATNTDGKNYCGLPG
EEECCCCCCCCCCCC
47.777619179
315PhosphorylationTNTDGKNYCGLPGEY
ECCCCCCCCCCCCCE
7.44-
316S-nitrosylationNTDGKNYCGLPGEYW
CCCCCCCCCCCCCEE
6.7125040305
322NitrationYCGLPGEYWLGNDKI
CCCCCCCEECCCCHH
16.32-
333PhosphorylationNDKISQLTRMGPTEL
CCHHHHHHHCCCCEE
15.80-
338PhosphorylationQLTRMGPTELLIEME
HHHHCCCCEEEEEEE
33.27-
348AcetylationLIEMEDWKGDKVKAH
EEEEECCCCCEEEEE
70.3430585629
353GlycationDWKGDKVKAHYGGFT
CCCCCEEEEEECCEE
34.88-
356NitrationGDKVKAHYGGFTVQN
CCEEEEEECCEEEEC
24.65-
356PhosphorylationGDKVKAHYGGFTVQN
CCEEEEEECCEEEEC
24.65-
368NitrationVQNEANKYQISVNKY
EECCCCCEEEEEEEC
15.75-
368PhosphorylationVQNEANKYQISVNKY
EECCCCCEEEEEEEC
15.7528270605
371PhosphorylationEANKYQISVNKYRGT
CCCCEEEEEEECCCC
12.2423911959
374AcetylationKYQISVNKYRGTAGN
CEEEEEEECCCCHHH
33.8827178108
375PhosphorylationYQISVNKYRGTAGNA
EEEEEEECCCCHHHH
14.7428270605
394N-linked_GlycosylationASQLMGENRTMTIHN
HHHHHCCCCEEEEEC
38.7116263699
394N-linked_GlycosylationASQLMGENRTMTIHN
HHHHHCCCCEEEEEC
38.7116263699
396PhosphorylationQLMGENRTMTIHNGM
HHHCCCCEEEEECCE
30.19-
408PhosphorylationNGMFFSTYDRDNDGW
CCEEEECEECCCCCC
14.0521253578
417PhosphorylationRDNDGWLTSDPRKQC
CCCCCCCCCCCCCCC
25.2822210691
418PhosphorylationDNDGWLTSDPRKQCS
CCCCCCCCCCCCCCC
43.3722210691
425PhosphorylationSDPRKQCSKEDGGGW
CCCCCCCCCCCCCCC
36.2628857561
434NitrationEDGGGWWYNRCHAAN
CCCCCCCCCCEEEEC
6.04-
452NitrationRYYWGGQYTWDMAKH
CEECCCEECCCHHHH
17.05-
452PhosphorylationRYYWGGQYTWDMAKH
CEECCCEECCCHHHH
17.05-
471AcetylationGVVWMNWKGSWYSMR
CEEEEECCCCHHHHC
37.757822959
475NitrationMNWKGSWYSMRKMSM
EECCCCHHHHCCCCC
8.35-
475PhosphorylationMNWKGSWYSMRKMSM
EECCCCHHHHCCCCC
8.35-
481PhosphorylationWYSMRKMSMKIRPFF
HHHHCCCCCCEECCC
21.6924719451

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of FIBB_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of FIBB_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference
208Acetylation206 (2)PLrs6054
  • Fibrinogen levels
26561523
255Phosphorylation265 (10)PLrs6054
  • Fibrinogen levels
26561523
261Phosphorylation265 (4)PLrs6054
  • Fibrinogen levels
26561523
262Phosphorylation265 (3)PLrs6054
  • Fibrinogen levels
26561523
264Acetylation265 (1)PLrs6054
  • Fibrinogen levels
26561523
266Phosphorylation265 (1)PLrs6054
  • Fibrinogen levels
26561523
269Phosphorylation265 (4)PLrs6054
  • Fibrinogen levels
26561523

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CALR_HUMANCALRphysical
7592883
SBDS_HUMANSBDSphysical
28514442
SPRE_HUMANSPRphysical
28514442
ADK_HUMANADKphysical
28514442
SYNC_HUMANNARSphysical
28514442
OXSR1_HUMANOXSR1physical
28514442
NAA15_HUMANNAA15physical
28514442
NDKB_HUMANNME2physical
28514442
PO2F1_HUMANPOU2F1physical
28514442
SLK_HUMANSLKphysical
28514442
TCEA1_HUMANTCEA1physical
28514442
EIF2A_HUMANEIF2Aphysical
28514442
BLVRB_HUMANBLVRBphysical
28514442
CTBL1_HUMANCTNNBL1physical
28514442
TBC24_HUMANTBC1D24physical
28514442
MP2K1_HUMANMAP2K1physical
28514442
UBCP1_HUMANUBLCP1physical
28514442
SNX3_HUMANSNX3physical
28514442
RHG01_HUMANARHGAP1physical
28514442
ATG3_HUMANATG3physical
28514442
VRK1_HUMANVRK1physical
28514442
PMVK_HUMANPMVKphysical
28514442
PPID_HUMANPPIDphysical
28514442
MCTS1_HUMANMCTS1physical
28514442
PUS7_HUMANPUS7physical
28514442
ARMT1_HUMANC6orf211physical
28514442
EF1A2_HUMANEEF1A2physical
28514442
PIR_HUMANPIRphysical
28514442
PAK2_HUMANPAK2physical
28514442
ITPA_HUMANITPAphysical
28514442
LZIC_HUMANLZICphysical
28514442
DUS3_HUMANDUSP3physical
28514442
VIGLN_HUMANHDLBPphysical
28514442
PUR8_HUMANADSLphysical
28514442
DENR_HUMANDENRphysical
28514442
HMCS1_HUMANHMGCS1physical
28514442
KIF2A_HUMANKIF2Aphysical
28514442
ERF1_HUMANETF1physical
28514442
FEN1_HUMANFEN1physical
28514442
UBE2T_HUMANUBE2Tphysical
28514442
GRAN_HUMANGCAphysical
28514442
LETM1_HUMANLETM1physical
28514442
PYM1_HUMANWIBGphysical
28514442
PSME2_HUMANPSME2physical
28514442
CGL_HUMANCTHphysical
28514442
OTUB1_HUMANOTUB1physical
28514442
FTO_HUMANFTOphysical
28514442
HDGR2_HUMANHDGFRP2physical
28514442
GPKOW_HUMANGPKOWphysical
28514442
PNPO_HUMANPNPOphysical
28514442
VP26A_HUMANVPS26Aphysical
28514442
NAA50_HUMANNAA50physical
28514442
RBM12_HUMANRBM12physical
28514442
K1143_HUMANKIAA1143physical
28514442
EIF3J_HUMANEIF3Jphysical
28514442
KPCI_HUMANPRKCIphysical
28514442
SF3A1_HUMANSF3A1physical
28514442
RPR1A_HUMANRPRD1Aphysical
28514442
PAPS1_HUMANPAPSS1physical
28514442
TLN1_HUMANTLN1physical
28514442
UBA1_HUMANUBA1physical
28514442
RPR1B_HUMANRPRD1Bphysical
28514442
SYFB_HUMANFARSBphysical
28514442
USO1_HUMANUSO1physical
28514442
DDAH1_HUMANDDAH1physical
28514442
TOPK_HUMANPBKphysical
28514442
CAB39_HUMANCAB39physical
28514442
RHOA_HUMANRHOAphysical
28514442
PTN11_HUMANPTPN11physical
28514442
TES_HUMANTESphysical
28514442
PYGB_HUMANPYGBphysical
28514442
RRP44_HUMANDIS3physical
28514442
SCRN1_HUMANSCRN1physical
28514442
PAK1_HUMANPAK1physical
28514442
GNAQ_HUMANGNAQphysical
28514442
SYAP1_HUMANSYAP1physical
28514442
SNX6_HUMANSNX6physical
28514442
PAPOA_HUMANPAPOLAphysical
28514442
LSM1_HUMANLSM1physical
28514442
GLSK_HUMANGLSphysical
28514442
T2FA_HUMANGTF2F1physical
28514442
GNL1_HUMANGNL1physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
202400Congenital afibrinogenemia (CAFBN)
616004Dysfibrinogenemia, congenital (DYSFIBRIN)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of FIBB_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-394, AND MASSSPECTROMETRY.
"Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach.";
Lewandrowski U., Moebius J., Walter U., Sickmann A.;
Mol. Cell. Proteomics 5:226-233(2006).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-394, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-394, AND MASSSPECTROMETRY.

TOP